Extraordinary Loss Due to Change in Estimated PCB Treatment Costs
First written in FY2018-Q2. 1 of 2 entries say "Restated". Latest entry: FY2018.
The whole theme swung hardest in 2017: 4 of 14 companies on the "Worse" side.
4 other companies' latest entry also says "Restated".
- FY2018RestatedAnnual report
「Accordingly, in the current consolidated fiscal year, the difference between the previous estimate and the revised estimate was recognized as an extraordinary loss for PCB treatment costs.」
The recognition of an extraordinary loss from a revision to the estimated cost of PCB treatment was reconfirmed in the full-year results. - FY2018-Q2First statedAnnual report
「The company had previously recognized an estimated cost for the treatment of polychlorinated biphenyl (PCB) waste. As progress was made in the treatment process, it became possible to estimate the treatment cost more precisely, and the estimate was revised. Accordingly, in the second quarter of the current consolidated fiscal year, the difference between the previous estimate and the revised estimate was recognized as an extraordinary loss for PCB treatment costs. As a result, profit before income taxes for the cumulative second quarter decreased by ¥3,850 million.」
A ¥3.850 billion extraordinary loss was recognized following a revision to the estimated cost of treating PCB waste.